Analysis of Causative Microorganism in 248 Primary Hip Arthroplasties Revised for Infection: A Study Using the NJR Dataset
Introduction This study aimed to describe the epidemiology of the causative organism in a series of primary hip arthroplasties revised for a diagnosis of periprosthetic joint infection (PJI) in England and Wales. Methods Patient data from the National Joint Registry (NJR) was linked to microbiology...
Gespeichert in:
Veröffentlicht in: | Hip international 2016-01, Vol.26 (1), p.82-89 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction
This study aimed to describe the epidemiology of the causative organism in a
series of primary hip arthroplasties revised for a diagnosis of
periprosthetic joint infection (PJI) in England and Wales.
Methods
Patient data from the National Joint Registry (NJR) was linked to
microbiology data held by Public Health England (PHE) which identified a
series of 248 primary hip arthroplasties revised for PJI between 2003 and
2014. Definitive cultures, isolated at time of revision surgery, were
available for all cases. Total hip arthroplasty (n = 239, 96%) and hip
resurfacing (n = 5, 2%) were the most commonly performed primary procedures.
A two-stage revision was the most common operative management (n = 174,
70%).
Results
202 (81%) cases were infected with a single genus microorganism and the most
commonly implicated genus was Staphylococcus species (70%
of all single genus infections). Staphylococcus species
were also the most commonly identified microorganism in mixed genus
infections (74% of patient's cultures). There was a significant difference
in microorganism distribution when comparing uncemented vs cement implant
fixation, with a higher incidence of Gram-negative infection observed in the
uncemented group (p = 0.048, Chi-square).
Conclusions
Both prophylactic and therapeutic antibiotic regimes should be focused on
targeting Staphylococci. |
---|---|
ISSN: | 1120-7000 1724-6067 |
DOI: | 10.5301/hipint.5000313 |